In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline
Stem Cell Reports · 2024-06 · 19 (6) · 767-795
DOI: 10.1016/j.stemcr.2024.05.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cell Reports, 2024-06. Verfasst von Marlene F Pereira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy; Department of Oncology and Hemato-Onc…. Hauptthemen laut MEDLINE: Benchmarking, Disease Models, Animal, Brain Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 317 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Research Council, Umberto Veronesi Foundation, Horizon 2020 Framework Programme.
Abstract (Originalsprache)
Human cellular models and their neuronal derivatives have afforded unprecedented advances in elucidating pathogenic mechanisms of neuropsychiatric diseases. Notwithstanding their indispensable contribution, animal models remain the benchmark in neurobiological research. In an attempt to harness the best of both worlds, researchers have increasingly relied on human/animal chimeras by xenografting human cells into the animal brain. Despite the unparalleled potential of xenografting approaches in the study of the human brain, literature resources that systematically examine their significance and advantages are surprisingly lacking. We fill this gap by providing a comprehensive account of brain diseases that were thus far subjected to all three modeling approaches (transgenic rodents, in vitro human lineages, human-animal xenografting) and provide a critical appraisal of the impact of xenografting approaches for advancing our understanding of those diseases and brain development. Next, we give our perspective on integrating xenografting modeling pipeline with recent cutting-edge technological advancements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Neu…
- Department of Experimental Oncology, European Institute of Oncology IRCCS, Via Adamello 16, 20139 Milan, Italy; Neurogenomics Centre, Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy. Electronic addres…
Förderung
- European Research Council
- Umberto Veronesi Foundation
- Horizon 2020 Framework Programme
- Horizon 2020
- H2020 Marie Skłodowska-Curie Actions
Zitieren
APA
Pereira, M. F., Shyti, R., & Testa, G. (2024). In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline. Stem Cell Reports, 19(6), 767-795. https://doi.org/10.1016/j.stemcr.2024.05.004
Vancouver
Pereira MF, Shyti R, Testa G. In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline. Stem Cell Reports. 2024;19(6):767-795. doi:10.1016/j.stemcr.2024.05.004
BibTeX
@article{Pereira2024,
author = {Pereira, Marlene F and Shyti, Reinald and Testa, Giuseppe},
title = {In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline},
journal = {Stem Cell Reports},
year = {2024},
volume = {19},
number = {6},
pages = {767--795},
doi = {10.1016/j.stemcr.2024.05.004}
}
EUVIMED